| 名稱(chēng) | FCGR2A/HEK293 |
| 型號(hào) | CBP74077 |
| 報(bào)價(jià) |  |
| 特點(diǎn) | FCGR2A/HEK293，凍存條件：90% FBS+10% DMSO； |
產(chǎn)品搜索
產(chǎn)品分類(lèi)
相關(guān)文章
- 假病毒標(biāo)準(zhǔn)品
- 第四代ALK激酶抑制劑篩選模型
- ATCC細(xì)胞株所用培養(yǎng)基有何要求？
- TLR激動(dòng)劑藥物細(xì)胞篩選模型
- 肺癌靶向治療：腫瘤不進(jìn)展時(shí)間超2年
- 【新品上線(xiàn)】多重病原菌質(zhì)控品
- 老靶點(diǎn)迭代突破創(chuàng)新：Her2靶點(diǎn)細(xì)胞模型
- 【靶點(diǎn)模型+診斷質(zhì)控】BTK C481S的藥物開(kāi)發(fā)和診斷
- 分享：CIRCULATE-Japan，輔助治療的“升級(jí)”和“降級(jí)”
- 從《指導(dǎo)原則》中分析參考品盤(pán)設(shè)計(jì)
聯(lián)系我們
聯(lián)系人：蔣經(jīng)理
電話(huà)：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
電話(huà)：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > 腫瘤免疫細(xì)胞株 > CBP74077FCGR2A/HEK293
- 詳細(xì)內(nèi)容
FCGR2A/HEK293
| CBP74077 | |
| I. Background | |
| FCGR2A (FcγRIIa) is a Protein Coding gene. Diseases associated with FCGR2A include Cystic Fibrosis and Systemic Lupus Erythematosus. Among its related pathways are Innate Immune System and Microglia Activation During Neuroinflammation: Overview. | |
| II. Description | |
| Recombinant HEK293 cells constitutively expressing FCGR2A. | |
| III. Introduction | |
| Host Cell: | HEK293 |
| Expressed gene: | FCGR2A（FcγRIIa） |
| Stability: | 32 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
| Synonym(s): | FCGR2A |
| Freeze Medium: | 90% FBS+10% DMSO |
| Culture Medium: | DMEM+10%FBS+Hygromycin 100ug/ml |
| Mycoplasma Testing: | Negative |
| Storage: | Liquid nitrogen |
| Application(s): | Binding Assay,FACS |
| IV. Description of Host Cell Line | |
| Organism: | Human |
| Tissue: | Kidney |
| Morphology: | Epitheloid cell |
| Growth Properties: | Adherent |
| Ⅴ. Representative Data | |
Figure 1.Recombinant HEK293 cells constitutively expressing FCGR2A(FcγRIIa). | |
會(huì)員_a.png)